CJ Bioscience, Inc.

CJ Foods and T&R Biofab aim to synergize their unique expertise and technologies to bring to the market innovative food products SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- CJ Foods, a business unit of South Korea-based CJ CheilJedang, announced that it entered into a joint development agreement (JDA) with T&R Biofab to develop alternative meat using 3D bioprinting technology. T&R Biofab is a med-tech company that develops artificial tissues using its world-class technology in the field of regenerative medicine based on 3D bioprinting. Through this collaboration, the two innovative Korean companies will leverage synergies between the food industry and the 3D printing medical field to elevate new plant-based alternative protein products up to consumers' expectations on taste, texture, appearance, and nutrition. Plant-based alternative protein food products beyond the limitations of today's offerings are seen as new growth engines for both companies. According to Bloomberg Intelligence, the plant-based food market is estimated to be worth USD 162 billion by 2030, showing a rapid growth from USD 24.9 billion in 2020. Plant-based food has emerged as a major trend, extending beyond concerns about animal welfare to be recognized for its positive impact on health, nutrition, and environmental. Nevertheless, one challenge has persisted – achieving the authentic texture and mouthfeel of animal-based food. "At CJ Foods, we recognize that breakthrough innovation happens at the interface of distinctly different proficiencies and industries," stated Dr. Florian Viton, Senior Vice President, Strategic Innovation at CJ Foods. "We see our partnership with T&R Biofab as a unique opportunity to create alternative protein offerings that truly surpass the limitations hindering today's plant-based products. This exciting collaboration is part of CJ Food's broader strategy to accelerate our pace of innovation and seed new growth engines in support of CJ Food's global ambitions." "As global leaders and public figures increasingly draw attention to the alternative protein food sector, particularly the potential within 3D printed food, it is imperative to underscore that this domain seldom unites genuine food industry experts with accomplished printing specialists," commented Dr. Paulo Marinho, Head of Scientific Strategy of T&R Biofab. "This partnership stands as a unique instance where these two domains converge and collaborate, each pioneering its own sphere to achieve a shared and essential solution." CJ Foods remains committed to developing and investing technologies aimed at securing sustainable food for the future. Notably, it launched a brand specializing in plant-based foods and offers plant-based Mandu products in both overseas and Korean markets. In addition, last year, CJ Foods introduced a plant-based beverage brand, Altive, through its in-house food venture program known as INNO 100. About CJ Foods CJ Foods, a business unit of CJ CheilJedang, is a global food company delivering a variety of products ranging from foodstuffs and frozen/chilled foods to appetizers. As the largest food company in Korea with global sales of 11.1 trillion KRW in 2022, CJ Foods is now leading the globalization of Korean food with its fast-growing bibigo brand. Under bibigo, CJ currently focuses on seven delicious Global Strategic Products of K-food, including Mandu (Korean-style dumpling), chicken, processed rice, Korean sauce, Kimchi, Gim (seaweed), and roll to global consumers. The company operates over 60 sites in multiple regions worldwide including South Korea, the U.S. (Schwan's Company), China, Japan, Southeast Asia, Europe, and Oceania. For more information, visit About CJ CheilJedang CJ CheilJedang is a South Korea-based food & bio company operating globally. Founded in 1953 as the first Korean sugar manufacturer, it is now a leading global food player with brands such as bibigo. It also provides advanced bio products including feed and food additives made by its cutting-edge, fermentation-based bioengineering technologies. The company recorded sales of 30 trillion KRW in 2022. CJ CheilJedang is part of CJ Group, an international company in the fields of Food & Food Services, Bio & Pharma, Entertainment & Media, and Retail & Logistics. For more information, visit About T&R Biofab T&R Biofab is a science-driven and fast-growing company which has developed its own 3D Bio-printing System and its own Proprietary Biomaterials for the creation of Implantable Medical Devices, Bio-surgical Solutions, 3D Organoid Models, and Artificial Organs. At its origin, T&R Biofab started its business with the development and commercialization of 3D Bio-printing equipment. Quickly, T&R recognized that there were unmet needs on the medical field where Bioprinting could offer a unique solution, however, to translate that science to products that would benefit society, the use of other cutting-edge technologies such as biomimetic biomaterials and stem cells were needed, and the company quickly expanded its R&D capabilities. After securing key IP, filing over 150 patents, and writing more than 200 SCI articles; T&R owns the core technology to address the most challenging problems in healthcare. Adding to this unique set of expertise, the longstanding collaborations with the biggest MedTech in the world, prepared T&R Biofab to what is necessary to achieve a globally successful product; therefore, delivering solutions that are not only needed but also reliable and impact-lasting. For more information, visit SOURCE CJ CheilJedang

CJ Olive Young to use polyhydroxyalkanoate (PHA) and polylactic acid (PLA) to make cushion container for popular "WAKEMAKE" brand in collaboration with CJ CheilJedang Company enters beauty market with alternative packaging solution to ABS WOBURN, Mass., Dec. 22, 2022 /PRNewswire/ -- CJ Biomaterials, Inc., a division of South Korea-based CJ CheilJedang and a primary producer of polyhydroxyalkanoate (PHA), has successfully developed cosmetic packaging for CJ Olive Young, a market-leading health and beauty retail chain in Korea. This new cosmetic case uses CJ Biomaterials' amorphous PHA technology in combination with polylactic acid (PLA) and will be sold under Olive Young's popular private brand, WAKEMAKE. Launched in Korea on December 21st, the 'WAKEMAKE Water Velvet Vegan Cushion' uses vegan cosmetic ingredients and eco-friendly bio-based packaging. CJ Olive Young has 1,200 stores across Korea and a global network in 150 countries. Continue Reading New cosmetic packaging has been developed that uses CJ Biomaterials’ amorphous PHA technology in combination with polylactic acid (PLA). This eco-friendly container was introduced in Korea for CJ Olive Young, a market-leading health and beauty retail chain. CJ Olive Young has 1,200 stores across Korea and a global network in 150 countries. PLA has experienced significant growth as a bio-based material in a broad range of finished product applications and is currently the most widely used industrial compostable material in the world, but it has certain limitations. Blending amorphous PHA in PLA leads to significant improvements in the mechanical properties of PLA, such as toughness and ductility leading to improved impact resistance and the creation of elegant shapes. CJ Biomaterials' amorphous PHA is a softer, more rubbery version of PHA that offers fundamentally different performance characteristics than the crystalline or semi-crystalline forms that currently dominate the PHA market. The 100% bio-sourced solution of amorphous PHA and PLA materials were applied to the entire outside of the WAKEMAKE container, replacing acrylonitrile butadiene styrene (ABS). Some developed countries and leading cosmetic brands are actively making efforts to replace ABS, a petroleum-based, non-biodegradable plastic that is currently widely used in cosmetic containers. This is the right time to introduce an eco-friendlier package. "This is an important milestone for CJ Biomaterials, and we expect that the application of bio-based materials in the consumer goods market will expand beyond the release of the WAKEMAKE cushion," says Seung-Jin Lee, Head of the Biomaterials business from CJ CheilJedang. "We will widely promote the use of PHA in various markets, as it is an eco-friendly material that is effective for industrial-scale use. We are proud that our PHA products—which are derived from nature and return to nature—are helping to meet the growing demands from brands and consumers for more environmentally friendly products." Today's announcement caps the end of a successful year for CJ Biomaterials. Earlier this year, the company announced commercial-scale production of PHA following the inauguration of its production facility in Pasuruan, Indonesia, becoming the only company in the world that can produce aPHA at scale, which includes CJ Biomaterials' first product under its new PHACT™ brand, named PHACT A1000P. The company also expanded its biomaterials business by establishing relationships with global organizations, including NatureWorks, Yuhan-Kimberly, the ACCOR hotel chain, and the makeup brand Banilla Co., which plans to launch cosmetics with containers made from bio-sourced materials in early 2023. For information on CJ Biomaterials, visit our website at . About CJ BIOMATERIALS CJ Biomaterials, a business unit of CJ BIO, is a part of CJ CheilJedang, a global lifestyle company with a vision to inspire a new life filled with health, happiness and convenience. CJ Group has organized its business portfolio into four core sectors: Food & Food Service, Bio & Pharma, Entertainment & Media, and Retail & Logistics. CJ BIO is the world's leading supplier of fermentation-based bioproducts for animal nutrition, human nutrition, and biomaterials at its thirteen manufacturing facilities worldwide. It is the mission of CJ Biomaterials to develop meaningful solutions to the global problem of plastic waste and other sustainability challenges at scale. CJ Biomaterials has been working toward bio-based chemicals and biopolymers as part of a long-term vision to expand into technologies that can help create a more sustainable future. CJ Biomaterials is a leader in the manufacture of polyhydroxyalkanoates (PHAs) – both polymers and related chemistries. We have the core technology platforms necessary to implement PHA-based solutions at scale including bioscience, chemical engineering, materials innovation and applications development. We have the technology, expertise and capacity to make an impact with PHA in global markets and important applications, ranging from flexible and rigid packaging, 3D printing and agricultural films to coatings, personal care, and healthcare. As a socially responsible company, CJ Biomaterials strives toward practicing carbon-neutral manufacturing operations by utilizing renewable raw materials and developing value-added coproducts to minimize environmental waste. Learn more about our amorphous PHA technology at: . Media Contact Resource Advantage Dan Green [email protected] CJ Biomaterials Heidi Lebel [email protected] SOURCE CJ BIO